

A thermally robust (≈400 °C), critically small‐size‐simple ligand structure ruthenium (Ru) precursor enables exceptional growth per cycle (≈1.28 Å cycle−1), short incubation (≈8 cycles), ultralow resistivity (8.65 µΩ cm) and outstanding substrate selectivity via atomic layer deposition (ALD) process at high temperatures, overcoming prior Ru‐ALD limitations, offering a scalable, impurity free pathway for next generation interconnects beyond copper. Abstract Ruthenium (Ru) via atomic layer deposition (ALD) has emerged as a promising alternative to copper‐interconnects. For the first time, a small yet simple molecular structure Ru precursor, [Ru(trimethylenemethane (TMM))(p‐cymene)], with excellent thermal stability up to 400 °C is introduced that enables a high‐temperature ALD‐Ru process with a high growth per cycle of ≈1.28 Å cycle−1 and a short incubation period (≈8 cycles) on TiN, facilitating uniform, dense film growth. The process achieves low impurity levels and resistivities as low as 10.6 µΩ cm at 350 °C without postannealing, approaching bulk Ru values (7.4 µΩ cm). Additionally, no Ru nucleation is observed on SiO2 even after 1000 cycles, indicating excellent substrate selectivity. Computational analyses confirm the substrate‐selective adsorption behavior of the precursor, favoring TMM‐terminated configurations on Ru and RuO2, while nucleation on SiO2 can be delayed. Fragmentation energy calculations further support the precursor's thermal robustness through strong Ru─ligand bonding. Advanced crystallography/microstructure analysis using electron backscatter diffraction reveals that the enhanced grain growth and the formation of low‐energy coincidence site lattice boundaries are critical for minimizing resistivity, which is supported by combined Fuchs–Sondheimer–Mayadas–Shatzkes modeling. These findings position the new Ru precursor as a robust candidate for durable, scalable ALD‐Ru processes in advanced interconnect technology. A thermally robust (≈400 °C), critically small-size-simple ligand structure ruthenium (Ru) precursor enables exceptional growth per cycle (≈1.28 Å cycle−1), short incubation (≈8 cycles), ultralow resistivity (8.65 µΩ cm) and outstanding substrate selectivity via atomic layer deposition (ALD) process at high temperatures, overcoming prior Ru-ALD limitations, offering a scalable, impurity free pathway for next generation interconnects beyond copper. Abstract Ruthenium (Ru) via atomic layer deposition (ALD) has emerged as a promising alternative to copper-interconnects. For the first time, a small yet simple molecular structure Ru precursor, [Ru(trimethylenemethane (TMM))( p -cymene)], with excellent thermal stability up to 400 °C is introduced that enables a high-temperature ALD-Ru process with a high growth per cycle of ≈1.28 Å cycle −1 and a short incubation period (≈8 cycles) on TiN, facilitating uniform, dense film growth. The process achieves low impurity levels and resistivities as low as 10.6 µΩ cm at 350 °C without postannealing, approaching bulk Ru values (7.4 µΩ cm). Additionally, no Ru nucleation is observed on SiO 2 even after 1000 cycles, indicating excellent substrate selectivity. Computational analyses confirm the substrate-selective adsorption behavior of the precursor, favoring TMM-terminated configurations on Ru and RuO 2, while nucleation on SiO 2 can be delayed. Fragmentation energy calculations further support the precursor's thermal robustness through strong Ru─ligand bonding. Advanced crystallography/microstructure analysis using electron backscatter diffraction reveals that the enhanced grain growth and the formation of low-energy coincidence site lattice boundaries are critical for minimizing resistivity, which is supported by combined Fuchs–Sondheimer–Mayadas–Shatzkes modeling. These findings position the new Ru precursor as a robust candidate for durable, scalable ALD-Ru processes in advanced interconnect technology. Advanced Science, EarlyView.
Medical Journal
|15th Jan, 2026
|Nature Medicine's Advance Online Publication (AOP) table of contents.
Medical Journal
|15th Jan, 2026
|Wiley
Medical Journal
|15th Jan, 2026
|Wiley
Medical Journal
|15th Jan, 2026
|Wiley
Medical Journal
|15th Jan, 2026
|Wiley
Medical Journal
|15th Jan, 2026
|Wiley
Medical Journal
|15th Jan, 2026
|Wiley